Dopamine-loaded lipid based nanocarriers for intranasal administration of the neurotransmitter: A comparative study. 2021

Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", Bari, Italy. Electronic address: adriana.trapani@uniba.it.

Both dopamine (DA) loaded Solid Lipid Nanoparticles (SLN) and liposomes (Lip), designed for intranasal administration of the neurotransmitter as an innovative Parkinson disease treatment, were already characterized in vitro in some extent by us (Trapani et al., 2018a and Cometa et al., 2020, respectively). Herein, to gain insight into the structure of SLN, X-ray Photoelectron Spectroscopy Analysis was carried out and DA-SLN (SLN 1) were found to exhibit high amounts of the neurotransmitter on the surface, whereas the external side of Glycol Chitosan (GCS) containing SLN (SLN 2) possessed only few amounts. However, SLN 2 were characterized by the highest encapsulation DA efficiency (i.e., 81%). Furthermore, in view of intranasal administration, mucoadhesion tests in vitro were also conducted for SLN and Lip formulations, evidencing high muchoadesive effect exerted by SLN 2. Concerning ex-vivo studies, SLN and Lip were found to be safe for Olfactory Ensheathing Cells and fluorescent SLN 2 were taken up in a dose-dependent manner reaching the 100% of positive cells, while Lip 2 (chitosan-glutathione-coated) were internalised by 70% OECs with six-times more lipid concentration. Hence, SLN 2 formulation containing DA and GCS may constitute interesting formulations for further studies and promising dosage form for non-invasive nose-to-brain neurotransmitter delivery.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D009830 Olfactory Bulb Ovoid body resting on the CRIBRIFORM PLATE of the ethmoid bone where the OLFACTORY NERVE terminates. The olfactory bulb contains several types of nerve cells including the mitral cells, on whose DENDRITES the olfactory nerve synapses, forming the olfactory glomeruli. The accessory olfactory bulb, which receives the projection from the VOMERONASAL ORGAN via the vomeronasal nerve, is also included here. Accessory Olfactory Bulb,Olfactory Tract,Bulbus Olfactorius,Lateral Olfactory Tract,Main Olfactory Bulb,Olfactory Glomerulus,Accessory Olfactory Bulbs,Bulb, Accessory Olfactory,Bulb, Main Olfactory,Bulb, Olfactory,Bulbs, Accessory Olfactory,Bulbs, Main Olfactory,Bulbs, Olfactory,Glomerulus, Olfactory,Lateral Olfactory Tracts,Main Olfactory Bulbs,Olfactorius, Bulbus,Olfactory Bulb, Accessory,Olfactory Bulb, Main,Olfactory Bulbs,Olfactory Bulbs, Accessory,Olfactory Bulbs, Main,Olfactory Tract, Lateral,Olfactory Tracts,Olfactory Tracts, Lateral,Tract, Lateral Olfactory,Tract, Olfactory,Tracts, Lateral Olfactory,Tracts, Olfactory
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D000268 Adhesiveness A property of the surface of an object that makes it stick to another surface. Adhesivenesses
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
March 2022, Nanomaterials (Basel, Switzerland),
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
July 2016, Colloids and surfaces. B, Biointerfaces,
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
September 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
January 2018, Molecular neurobiology,
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
February 2023, Pharmaceutics,
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
November 2016, Nanomedicine (London, England),
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
January 2013, International journal of pharmaceutics,
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
December 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
May 2024, Neuropharmacology,
Adriana Trapani, and Elvira De Giglio, and Stefania Cometa, and Maria Addolorata Bonifacio, and Laura Dazzi, and Sante Di Gioia, and Md Niamat Hossain, and Rosalia Pellitteri, and Sophia G Antimisiaris, and Massimo Conese
July 2020, Pharmaceutics,
Copied contents to your clipboard!